NPCE
Neuropace Inc
NASDAQ: NPCE · HEALTHCARE · MEDICAL DEVICES
$14.04
+1.23% today
Updated 2026-09-11
Market cap
$511.43M
P/E ratio
—
P/S ratio
4.78x
EPS (TTM)
$-0.48
Dividend yield
—
52W range
$9 – $20
Volume
0.2M
Neuropace Inc (NPCE) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$14.04
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$12.42
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B | $0.2B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 19.44% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -17.90%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.